Poland · Delayed Price · Currency is PLN InventionMed Statistics
Total Valuation
InventionMed has a market cap or net worth of PLN 22.41 million. The enterprise value is 25.18 million.
| Market Cap | 22.41M |
| Enterprise Value | 25.18M |
Important Dates
The next confirmed earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
InventionMed has 202.79 million shares outstanding.
| Current Share Class | 201.79M |
| Shares Outstanding | 202.79M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.61% |
| Owned by Institutions (%) | n/a |
| Float | 113.77M |
Valuation Ratios
The trailing PE ratio is 531.65.
| PE Ratio | 531.65 |
| Forward PE | n/a |
| PS Ratio | 5.99 |
| PB Ratio | 48.25 |
| P/TBV Ratio | 53.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 597.37 |
| EV / Sales | 6.73 |
| EV / EBITDA | 10.10 |
| EV / EBIT | 15.77 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22, with a Debt / Equity ratio of 6.07.
| Current Ratio | 0.22 |
| Quick Ratio | 0.22 |
| Debt / Equity | 6.07 |
| Debt / EBITDA | 1.13 |
| Debt / FCF | -3.99 |
| Interest Coverage | 1.02 |
Financial Efficiency
Return on equity (ROE) is 6.53% and return on invested capital (ROIC) is 48.52%.
| Return on Equity (ROE) | 6.53% |
| Return on Assets (ROA) | 2.57% |
| Return on Invested Capital (ROIC) | 48.52% |
| Return on Capital Employed (ROCE) | 6.33% |
| Weighted Average Cost of Capital (WACC) | 10.53% |
| Revenue Per Employee | 935,732 |
| Profits Per Employee | 10,537 |
| Employee Count | 4 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.04% in the last 52 weeks. The beta is 0.38, so InventionMed's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -37.04% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.12 |
| Relative Strength Index (RSI) | 52.71 |
| Average Volume (20 Days) | 79,441 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, InventionMed had revenue of PLN 3.74 million and earned 42,148 in profits. Earnings per share was 0.00.
| Revenue | 3.74M |
| Gross Profit | 3.60M |
| Operating Income | 1.60M |
| Pretax Income | 42,148 |
| Net Income | 42,148 |
| EBITDA | 2.49M |
| EBIT | 1.60M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 46,884 in cash and 2.82 million in debt, with a net cash position of -2.77 million or -0.01 per share.
| Cash & Cash Equivalents | 46,884 |
| Total Debt | 2.82M |
| Net Cash | -2.77M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 464,414 |
| Book Value Per Share | 0.00 |
| Working Capital | -11.28M |
Cash Flow
In the last 12 months, operating cash flow was -318,114 and capital expenditures -387,814, giving a free cash flow of -705,928.
| Operating Cash Flow | -318,114 |
| Capital Expenditures | -387,814 |
| Depreciation & Amortization | 896,993 |
| Net Borrowing | 736,447 |
| Free Cash Flow | -705,928 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 96.17%, with operating and profit margins of 42.66% and 1.13%.
| Gross Margin | 96.17% |
| Operating Margin | 42.66% |
| Pretax Margin | 1.13% |
| Profit Margin | 1.13% |
| EBITDA Margin | 66.63% |
| EBIT Margin | 42.66% |
| FCF Margin | n/a |
Dividends & Yields
InventionMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.19% |
| FCF Yield | -3.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 6, 2022. It was a forward split with a ratio of 4.
| Last Split Date | Sep 6, 2022 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
InventionMed has an Altman Z-Score of -0.84 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.84 |
| Piotroski F-Score | 5 |